$3.12
-0.01-0.32%
가까이에: Nov 19, 4:00 PM EST
$3.12
-0.01-0.32%
프리마켓: 4:09 AM EST

The average analyst price target for Whitehawk Therapeutics is $8.60, 175.6% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $7 to $10. The latest change came on Oct 1, 2026, when Stifel initiated coverage of Whitehawk Therapeutics with a Buy rating and a $9 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months